Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Silencing STAT3 enhances sensitivity of cancer cells to doxorubicin and inhibits tumor progression
Navneet Joshi, Farnaz Hajizadeh, Ehsan Ansari Dezfouli, et al.
Life Sciences (2021) Vol. 275, pp. 119369-119369
Closed Access | Times Cited: 36

Showing 1-25 of 36 citing articles:

Doxorubicin and other anthracyclines in cancers: Activity, chemoresistance and its overcoming
Roberto Mattioli, Andrea Ilari, Beatrice Colotti, et al.
Molecular Aspects of Medicine (2023) Vol. 93, pp. 101205-101205
Open Access | Times Cited: 103
The role of Th17 cells in the pathogenesis and treatment of breast cancer
Vahid Karpisheh, Majid Ahmadi, Kazem Abbaszadeh‐Goudarzi, et al.
Cancer Cell International (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 49
Overcoming doxorubicin resistance in cancer: siRNA-loaded nanoarchitectures for cancer gene therapy
Mahshid Deldar Abad Paskeh, Hamidreza Saebfar, Mahmood Khaksary Mahabady, et al.
Life Sciences (2022) Vol. 298, pp. 120463-120463
Open Access | Times Cited: 48
Quercetin as a JAK–STAT inhibitor: a potential role in solid tumors and neurodegenerative diseases
Hamidreza Zalpoor, Mohsen Nabi‐Afjadi, Razieh Forghaniesfidvajani, et al.
Cellular & Molecular Biology Letters (2022) Vol. 27, Iss. 1
Open Access | Times Cited: 38
Overcoming Acquired Drug Resistance to Cancer Therapies through Targeted STAT3 Inhibition
Sunanda Singh, Héctor W. Gómez, Shreya Thakkar, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4722-4722
Open Access | Times Cited: 21
Functionalized siRNA-chitosan nanoformulations promote triple-negative breast cancer cell death via blocking the miRNA-21/AKT/ERK signaling axis: in-silico and in vitro studies
Shaymaa A. Abdulmalek, Abdulrahman M. Saleh, Yasmin R. Shahin, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024) Vol. 397, Iss. 9, pp. 6941-6962
Open Access | Times Cited: 8
The roles of metabolic profiles and intracellular signaling pathways of tumor microenvironment cells in angiogenesis of solid tumors
Hamidreza Zalpoor, Fatemeh Aziziyan, Mahsa Liaghat, et al.
Cell Communication and Signaling (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 35
Current understanding of epigenetics role in melanoma treatment and resistance
Mohsen Karami Fath, Ali Azargoonjahromi, Asma Soofi, et al.
Cancer Cell International (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 28
Macrophage’s role in solid tumors: two edges of a sword
Arian Jahandideh, Mahsa Yarizadeh, Maryam Noei-Khesht Masjedi, et al.
Cancer Cell International (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 18
Th17 cell function in cancers: immunosuppressive agents or anti-tumor allies?
Marjan Anvar, Kimiya Rashidan, Nima Arsam, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 5
Blockade of CD73 using siRNA loaded chitosan lactate nanoparticles functionalized with TAT-hyaluronate enhances doxorubicin mediated cytotoxicity in cancer cells both in vitro and in vivo
Armin Mahmoud Salehi Khesht, Vahid Karpisheh, Parisa Sahami Gilan, et al.
International Journal of Biological Macromolecules (2021) Vol. 186, pp. 849-863
Closed Access | Times Cited: 34
The Role of Natural Products as Inhibitors of JAK/STAT Signaling Pathways in Glioblastoma Treatment
Hanieh Fahmideh, Hooriyeh Shapourian, Rasol Moltafeti, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-17
Open Access | Times Cited: 23
A cellular and molecular biology-based update for ivermectin against COVID-19: is it effective or non-effective?
Mohsen Nabi‐Afjadi, Fatemeh Mohebi, Hamidreza Zalpoor, et al.
Inflammopharmacology (2023) Vol. 31, Iss. 1, pp. 21-35
Open Access | Times Cited: 14
Recent advances in targeted gene silencing and cancer therapy by nanoparticle-based delivery systems
Hongyan Liu, Xialin Zhu, Yuyan Wei, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 157, pp. 114065-114065
Open Access | Times Cited: 18
The oncogenic mechanisms of the Janus kinase-signal transducer and activator of transcription pathway in digestive tract tumors
Ruihong Zhao, Zhangmin Hu, Xiaoli Zhang, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 3
Rolling Circle Amplification-Based Self-Assembly to Form a “GPS-Nanoconveyor” for In Vitro Targeted Imaging and Enhanced Gene/Chemo (CRISPR/DOX) Synergistic Therapy
Huan Du, Fang Wang, Ruyan Zhang, et al.
Biomacromolecules (2024) Vol. 25, Iss. 8, pp. 4991-5007
Closed Access | Times Cited: 3
The sensitivity of acute myeloid leukemia cells to cytarabine is increased by suppressing the expression of Heme oxygenase-1 and hypoxia-inducible factor 1-alpha
Mohammad Reza Sadeghi, Asma Moslehi, Hadiseh Kheiry, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 2
Rolling Circle Amplification-Based DNA Nano-Assembly for Targeted Drug Delivery and Gene Therapy
Zhiqing Zhang, Dongyan Xu, Jiawei Wang, et al.
Biomacromolecules (2022) Vol. 24, Iss. 1, pp. 439-448
Closed Access | Times Cited: 13
Targeted Silencing of NRF2 by rituximab-conjugated nanoparticles increases the sensitivity of chronic lymphoblastic leukemia cells to Cyclophosphamide
Atefeh Khodakarami, Mahsa Afsari Kashani, Atefeh Nazer, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 6
Oligonucleotide-Based Therapeutics for STAT3 Targeting in Cancer—Drug Carriers Matter
Sara Molenda, Agata Sikorska, Anna Florczak, et al.
Cancers (2023) Vol. 15, Iss. 23, pp. 5647-5647
Open Access | Times Cited: 6
RETRACTED ARTICLE: Dual Blockade of PD-1 and LAG3 Immune Checkpoints Increases Dendritic Cell Vaccine Mediated T Cell Responses in Breast Cancer Model
Asal Barshidi, Vahid Karpisheh, Fatemeh Karimian Noukabadi, et al.
Pharmaceutical Research (2022) Vol. 39, Iss. 8, pp. 1851-1866
Closed Access | Times Cited: 9
Moringa oleifera and Its Biochemical Compounds: Potential Multi-targeted Therapeutic Agents Against COVID-19 and Associated Cancer Progression
Ali Yousefi Rad, Ali Asghar Rastegari, Kahin Shahanipour, et al.
Biochemical Genetics (2024)
Closed Access | Times Cited: 1
Increased susceptibility to doxorubicin-induced cell death in acute lymphocytic leukemia cells by inhibiting serine/threonine WEE1 kinase expression using the chitosan-carboxymethyl dextran-polyethylene glycol-TAT nanoparticles
Abbas Ali Hosseinpour Feizi, Sajjad Vakili‐Samiani, Vahid Karpisheh, et al.
Journal of Drug Delivery Science and Technology (2022) Vol. 77, pp. 103868-103868
Closed Access | Times Cited: 8
A novel NFAT1-IL6/JAK/STAT3 signaling pathway related nomogram predicts overall survival in gliomas
Chao Zhang, Yu Wang, Wei Shao, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 4
Enhanced Cytotoxic Effect of TAT–PLGA-Embedded DOXO Carried by Biomimetic Magnetic Nanoparticles upon Combination with Magnetic Hyperthermia and Photothermia
Ylenia Jabalera, Alberto Sola‐Leyva, Salvatore Calogero Gaglio, et al.
Pharmaceutics (2021) Vol. 13, Iss. 8, pp. 1168-1168
Open Access | Times Cited: 9
Page 1 - Next Page

Scroll to top